To further confirm that PKM2 blockade can reverse lupus progress in the MRL/lpr mice, 20-week-old MRL/lpr mice, which have been developed spontaneous lupus-like lesions, were used to carry out the experiments. Here, PKM is linked to systemic lupus erythematosus.